These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2920218)

  • 1. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
    Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
    Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.
    Noworolska A; Slesak B; Harłonzińska A; Richter R
    Neoplasma; 1991; 38(1):57-62. PubMed ID: 2011210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
    Noworolska A; Harłozińska A; Richter R; Brodzka W
    Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
    Noworolska A; Harłozińska-Szmyrka A; Richter R
    Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between myelomonocytic, myeloid and nonspecific cross-reacting (NCA) antigens during myelocytic cell differentiation.
    Harłozińska A; Noworolska A; Majdic O; Richter R; Kotlarek-Haus S
    Br J Cancer; 1987 Dec; 56(6):787-90. PubMed ID: 2449236
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P; Chavanel G; Hendrick JC; Frenoy N
    J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia.
    Frénoy N; Ben-Bunant M; Berruel C; Child JA; Gendron MC; Missett JL; Razafimahaleo E; Burtin P
    Br J Cancer; 1982 Nov; 46(5):765-72. PubMed ID: 6756460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a species of non-specific cross-reacting antigen (NCA) expressed by human monocytic cell lines: structure and expression during cell differentiation.
    Kuroki M; Yamanaka T; Matsuo Y; Ohtani T; Matsuo Y; Minowada J; Misumi Y; Oikawa S; Nakazato H; Matsuoka Y
    Int J Cancer; 1994 Mar; 56(6):886-91. PubMed ID: 8119777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
    Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
    Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
    Scheinberg DA; Tanimoto M; McKenzie S; Strife A; Old LJ; Clarkson BD
    Leukemia; 1989 Jun; 3(6):440-5. PubMed ID: 2725060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of NCA in patients with chronic myelocytic leukemia.
    Wahren B; Gahrton G; Rudén U; Hammarström S
    Int J Cancer; 1982 Feb; 29(2):133-7. PubMed ID: 6949877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of CD66, CD67, and NCA in human neutrophils.
    Ducker TP; Skubitz KM
    J Leukoc Biol; 1992 Jul; 52(1):11-6. PubMed ID: 1640165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
    Audette M; Buchegger F; Schreyer M; Mach JP
    Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of anti K562 monoclonal antibodies with leukemic cells of myeloid lineage.
    Chiplunkar SV; Maniar HS; Tatake RJ; Amin KM; Advani SH; Gangal SG
    Leuk Res; 1990; 14(1):69-75. PubMed ID: 1689437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
    Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
    Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia.
    Haus O; Noworolska A; Laskowski M; Kuliszkiewicz-Janus M; Kozłowska J; Harłozińska-Szmyrka A; Jagielski J; Kotlarek-Haus S
    Exp Mol Pathol; 1990 Apr; 52(2):235-42. PubMed ID: 2332039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
    Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
    Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.